Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03848923 · ClinicalTrials.gov registry record
Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
A clinical trial of Neonatal Thrombocytopenia, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 160
- Enrollment target
- 2
- Study locations
NCT03848923 is a study of Neonatal Thrombocytopenia that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 160 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT03848923, a study of Neonatal Thrombocytopenia, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective observational study that was designed with the following two Specific Aims: 1. To determine whether the Immature Platelet Fraction percentage (IPF%) and the Immature Platelet Count (IPC) are better predictors of bleeding than the platelet count alone in neonates of different gestational and post-conceptional ages and with different etiologies of thrombocytopenia; and 2. To characterize the effects of neonatal thrombocytopenia and platelet transfusions (PLT Tx) on bleeding and on markers of systemic inflammation, thrombosis, and neutrophil extracellular traps (NET) formation in neonates with different underlying conditions.
Conditions Studied
Study Locations (2)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2026-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03848923
The ClinicalTrials.gov registry entry for NCT03848923 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Thrombocytopenia appearing as the primary indexed condition, and to 0 interventions.
NCT03848923 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03848923 about?
NCT03848923 is a clinical study titled "Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation". This is a prospective observational study that was designed with the following two Specific Aims: 1. To determine whether the Immature Platelet Fraction percentage (IPF%) and the Immature Platelet Count (IPC) are better predictors of bleeding than the platelet count alone in neonates of different g...
What is the current status of trial NCT03848923?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2019-08-19. Estimated completion is 2026-09-01.
What conditions does trial NCT03848923 study?
This clinical trial studies the following conditions: Neonatal Thrombocytopenia.
Who is sponsoring clinical trial NCT03848923?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03848923 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Thrombocytopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.